The GMED and K2M actions are of interest because the two made acquisitions to further their strategies with emerging technologies that the majority of competitors aren't pursuing.
Arthrex, DJO, NuVasive, Aesculap, Wright Medical, Globus Medical, ConMed, Orthofix, Exactech and Acumed range in annual revenue from $250 million to $2 billion and account for ~16% of the orthopaedic market's $48.1 billion.
A small device company with a novel technology interviewed 20 VAC members to gain market insight early in its development stage. The result? Its VAC approval rate is over 90% within 90 days of submitting its application.
The kit is a response to surgeons' needs for a simplified system that enhances OR efficiency and minimizes procedure delay, while appealing to the hospital's cost reduction initiatives.
Titan Spine reported +49% year-over-year sales growth at the end of 2Q17, driven by increased demand for its nanoLOCK® surface technology. Since 4Q16 launch, nanoLOCK has been implanted 2,500 times by 150 surgeons in nearly 100 hospitals.
If design validation were only user testing, the regulation would not allow for simulated use conditions. FDA clarifies these requirements in its Design Control Guidance.
It's been just over 8 weeks since OMTEC 2017 concluded...and already 70 orthopaedic-focused companies have confirmed their commitment to serve the needs of OEM attendees next June. Search the exhibitor list today and identify your next new partner...then meet face-to-face at OMTEC!
Measuring the work required to support each customer--or in many cases, each category of customer--can result in more effective management of the customer's "less-desirable" behavior and optimization of marketing to attract the types of customers that generate more profitable work.
We asked Jan Wahlström, Group Chief Executive Officer for Elos Medtech, to offer insight on the company's orthopaedic business since its 2015 acquisition of Onyx Medical.
